Alvotech

Third Time Might Be a Charm for Alvotech as FDA Accepts BLA for Humira Biosimilar
Third Time Might Be a Charm for Alvotech as FDA Accepts BLA for Humira Biosimilar
BioSpace
Alvotech
FDA
biosimilars
AVT02
AbbVie
Humira
Flag link:
Alvotech gets new FDA review for Humira biosimilar
Alvotech gets new FDA review for Humira biosimilar
BioPharma Dive
Alvotech
FDA
Humira
biosimilars
Flag link:
Teva expands Alvotech collab with 2 more biosims, increased manufacturing oversight and a $40M investment
Teva expands Alvotech collab with 2 more biosims, increased manufacturing oversight and a $40M investment
Fierce Pharma
Teva Pharmaceutical
Alvotech
biosimilars
Humira
AbbVie
drug manufacturing
Flag link:
Alvotech to raise cash after third FDA rejection for Humira biosimilar
Alvotech to raise cash after third FDA rejection for Humira biosimilar
BioPharma Dive
Alvotech
Teva Pharmaceutical
AbbVie
Humira
biosimilars
FDA
Flag link:
Johnson & Johnson inks another Stelara patent settlement, this time with Alvotech and Teva
Johnson & Johnson inks another Stelara patent settlement, this time with Alvotech and Teva
Fierce Pharma
JNJ
Stelara
biosimilars
legal
patents
Teva Pharmaceutical
Alvotech
Flag link:
Go or no go? Key FDA decisions for Argenx and Regeneron
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
FDA
Albireo Pharma
Aldeyra Therapeutics
Alvotech
Amneal Pharmaceuticals
Argenx
ARS Pharmaceuticals
AstraZeneca
Bayer
Bio-Thera Solutions
Biogen
BioMarin Pharmaceutical
Bristol Myers Squibb
Eisai
Eton Pharmaceuticals
F2G
Fabre-Kramer Pharmaceuticals
Fresenius
GSK
Intercept Pharmaceuticals
Ipsen
Ironwood Pharmaceuticals
Merck
Novaliq
Pfizer
Regeneron
Roche
Sanofi
Sarepta Therapeutics
Shionogi
Swedish Orphan Biovitrum
Takeda
Teva Pharmaceutica
UCB Pharma
Flag link:
Teva's Partner Alvotech Receives Complete Response Letter For AVT02 BLA
Teva's Partner Alvotech Receives Complete Response Letter For AVT02 BLA
Business Insider
Teva Pharmaceutical
Alvotech
AVT02
FDA
Humira
biosimilars
Flag link:
FDA rejects Teva’s high-potency biosimilar of Humira again
FDA rejects Teva’s high-potency biosimilar of Humira again
Pharmaphorum
Teva Pharmaceutical
Alvotech
biosimilars
FDA
Humira
Flag link:
Go or no go? Seagen's Padcev eyes FDA approval
Go or no go? Seagen's Padcev eyes FDA approval
EP Vantage
FDA
AbbVie
Alvotech
Ascendis Pharma
Astellas
AstraZeneca
Biogen
Daiichi Sankyo
Eli Lilly
Ferring Pharmaceuticals
Hugel
Innoviva
Ionis Pharmaceuticals
Lundbeck
Merck
Novo Nordisk
Otsuka
Pfizer
Roche Seagen
Seres Therapeutics
Takeda
UCB
Vertex Pharmaceuticals
Flag link:
FDA holds back Alvotech’s Humira biosimilar over manufacturing issues
FDA holds back Alvotech’s Humira biosimilar over manufacturing issues
BioPharma Dive
Alvotech
AbbVie
Humira
biosimilars
FDA
drug manufacturing
Flag link:
Alvotech Initiates Patient Study for AVT06, a Proposed Biosimilar for Eylea®
Alvotech Initiates Patient Study for AVT06, a Proposed Biosimilar for Eylea®
BioSpace
Alvotech
AVT06
biosimilars
clinical trials
Eylea
Flag link:
J&J's crown jewel Stelara faces another potential rival as biosim player Alvotech touts trial win
J&J's crown jewel Stelara faces another potential rival as biosim player Alvotech touts trial win
Fierce Pharma
Alvotech
Teva Pharmaceutical
JNJ
Stelara
AVT04
biosimilars
psoriasis
Flag link:
AbbVie, Alvotech settle Humira patent and trade secrets disputes, teeing up another biosim rollout next year
AbbVie, Alvotech settle Humira patent and trade secrets disputes, teeing up another biosim rollout next year
Fierce Pharma
Alvotech
AbbVie
Humira
biosimilars
legals
patents
trade secrets
Flag link:
Alvotech, battling AbbVie over its Humira biosim, raises $450M and tees up Nasdaq debut
Alvotech, battling AbbVie over its Humira biosim, raises $450M and tees up Nasdaq debut
Fierce Pharma
Alvotech
SPACs
AbbVie
Humira
Flag link:
Alvotech scores in AbbVie trade secrets case, but the Humira patent fight will stretch into next year
Alvotech scores in AbbVie trade secrets case, but the Humira patent fight will stretch into next year
Fierce Pharma
Alvotech
AbbVie
patents
Humira
trade secrets
biosimilars
Flag link:
AbbVie’s last stand: How an Icelandic billionaire’s biosimilar has one final shot to dethrone Humira
AbbVie’s last stand: How an Icelandic billionaire’s biosimilar has one final shot to dethrone Humira
Endpoints
AbbVie
biosimilars
Humira
Alvotech
Flag link:
Alvotech, not content to line up behind other Humira biosims, sues AbbVie over 'wrongful monopoly'
Alvotech, not content to line up behind other Humira biosims, sues AbbVie over 'wrongful monopoly'
Fierce Pharma
AbbVie
patents
biosimilars
Humira
Alvotech
Flag link:
AbbVie accuses rival of stealing blockbuster ‘trade secrets’ as clock ticks down on biosimilar assault
AbbVie accuses rival of stealing blockbuster ‘trade secrets’ as clock ticks down on biosimilar assault
Endpoints
AbbVie
Humira
trade secrets
Alvotech
Flag link:
DEAL WATCH: Biosimilars, Biosimilars and More Biosimilars
DEAL WATCH: Biosimilars, Biosimilars and More Biosimilars
Big Molecule Watch
biosimilars
Henlius
Ascentage
rituximab
Bioeq
Alvotech
Coherus
Biogen
Samsung Bioepis
Flag link: